Information 

New Health and Medical Technology Development Opportunities

The National Science Foundation Small Business Innovation Research program offers small firms and startups new health and medical technology development opportunities that will companies to produce novel, marketable, problem-solving solutions. The attachments provide basic information about how your small firm/startup can obtain non-dilutive seed funding that will help your company succeed in 2022 and beyond. More importantly, the attachments outline specific information about new health and medical technology development opportunities in the following areas:

Artificial Intelligence

Biomedical

Digital Health

Medical Devices

Funding Your Startup From Product Development To Business Growth

Moving your health technology startup or MedTech startup from product development to business growth requires money. In fact, each business development stage demands different types of funding. For example, a seed grant is used to conduct concept feasibility and produce a health or medical technology prototype. Other funding sources, such a convertible note, a working line of credit and a private early-stage investment, are needed for executing the Go-To-Market strategy, customer acquisition, and overall business growth.

This free brief provides information and illustrates the various funding sources, such as a seed grant, a convertible note, a working line of credit and a early-stage investment, required to move your startup from product development to business growth. In addition, it will show how a business model can be used to acquire funding at each business development stage.

Case Study: NSF SBIR Phase I Winner- Sterile Geeks VR

Sterile Geeks VR, a Jacksonville, FL-based MedTech startup, had its National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I funding proposal accepted. The NSF SBIR $256K new technology seed grant will be used to demonstrate Sterile Geeks' STEAMVision™ concept feasibility.

Attached is a brief regarding Sterile Geeks' efforts winning the NSF SBIR Phase I funding. It also provides the NSF SBIR proposal reviewers' comments about the company's proposed concept and opportunity for success.

Sterile Geeks' CEO and Eighteen Ventures worked closely to ensure that the company prepared (1) sound, strong convincing NSF SBIR Phase I proposal documents leading to seed funding, and (2) an actionable, realistic business model supporting the startup's overall long-term business development strategy.

Contact Mr. Darrell Williams, Darrell@Eighteenventures.com, to learn how Eighteen Ventures can help your company acquire NSF SBIR new health technology or medical technology development seed funding.